Issue 4/2015

New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers (509 — 520)

L. ZAVESKY, E. JANDAKOVA, R. TURYNA, L. LANGMEIEROVA, V. WEINBERGER, L. MINAR, M. KOHOUTOVA

DOI: 10.4149/neo_2015_062

3D multicellular models reflect the efficiency of MSC-directed enzyme/prodrug treatment (521 — 530)

R. BOHOVIC, L. DEMKOVA, M. CIHOVA, S. SKOLEKOVA, E. DURINIKOVA, L. TORO, S. TYCIAKOVA, Z. KOZOVSKA, M. MATUSKOVA, L. KUCEROVA

DOI: 10.4149/neo_2015_063

A recombined fusion protein SP5.2/tTF induce thrombosis in tumor blood vessel (531 — 540)

S. LV, M. YE, X. WANG, Z. LI, X. CHEN, X. DOU, Y. DAI, F. ZENG, L. LUO, C. WANG, K. LI, X. LUO, J. YAN, X. LI

DOI: 10.4149/neo_2015_064

Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1 (541 — 549)

C. WANG, G. YAN, Y. ZHANG, X. JIA, P. BU

DOI: 10.4149/neo_2015_065

Upregulation of microRNA-200a associates with tumor proliferation, CSCs phenotype and chemosensitivity in ovarian cancer (550 — 559)

N. LIU, L. ZHONG, J. ZENG, X. ZHANG, Q. YANG, D. LIAO, Y. WANG, G. CHEN, Y. WANG

DOI: 10.4149/neo_2015_066

miR-1271 inhibits OSCC cell growth and metastasis by targeting ALK (559 — 566)

D. KONG, G. ZHANG, H. MA, G. JIANG

DOI: 10.4149/neo_2015_067

Down-regulation of miR-205 promotes stemness of hepatocellular carcinoma cells by targeting PLCβ1 and increasing CD24 expression (567 — 573)

J. ZHAO, G. XU, Y. WANG, D. QIAN, Y. WANG, Y. X. LI

DOI: 10.4149/neo_2015_068

Effect of TNFRSF6B neutralization antibody on cell growth suppression and apoptosis induction in glioma cells (574 — 581)

Y. RUAN, S. HUANG, D. HE, R. GOPAUL, Z. LI, G. CHEN

DOI: 10.4149/neo_2015_069

Induction of apoptosis by capsaicin in hepatocellular cancer cell line SMMC-7721 is mediated through ROS generation and activation of JNK and p38 MAPK pathways (582 — 591)

H. Q. BU, K. CAI, F. SHEN, X. D. BAO, Y. XU, F. YU, H. Q. PAN, C. H. CHEN, Z. J. DU, J. H. CUI

DOI: 10.4149/neo_2015_070

Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer (592 — 601)

X. FENG, Q. SONG, A. YU, H. TANG, Z. PENG, X. WANG

DOI: 10.4149/neo_2015_071

Preoperative serum CA125 is an independent predictor for prognosis in operable patients with non-small cell lung cancer (602 — 609)

L. YING, J. WU, D. ZHANG, Z. LI, D. LI, X. PAN, H. LV, J. FENG

DOI: 10.4149/neo_2015_072

Clinicopathologic, surgical characteristics and survival outcomes of rectal gastrointestinal stromal tumors (610 — 617)

C. SHEN, H. CHEN, R. YIN, Y. YIN, J. CHEN, L. HAN, B. ZHANG, Z. CHEN, J. CHEN

DOI: 10.4149/neo_2015_073

Biological and clinical characteristics of patients with chronic lymphocytic leukemia with the IGHV3-21 and IGHV1-69; analysis of data from a single center (618 — 626)

R. URBANOVA, L. HUMPLIKOVA, H. DRIMALOVA, V. PROCHAZKA, P. TURCSANYI, Z. PIKALOVA, M. HOLZEROVA, L. KRUZOVA, M. JAROSOVA, J. URBAN, J. VRBKOVA, K. INDRAK, T. PAPAJIK

DOI: 10.4149/neo_2015_074

Prognostic value of interim and restaging PET/CT in Hodgkin lymphoma. Results of the CHEAP (Chemotherapy Effectiveness Assessment by PET/CT) study – long term observation (627 — 634)

Z. MILTENYI, S. BARNA, I. GARAI, Z. SIMON, A. JONA, F. MAGYARI, M. GERGELY, Z. NAGY, K. KERESZTES, P. PETTENDI, A. ILLES

DOI: 10.4149/neo_2015_075

Influence of surgical resection of hepatocellular carcinoma(HCC) for hematogenous dissemination of HCC cells and its effect on recurrence and metastasis: 3 years prospective study (635 — 640)

Y. LIU, Y. R. WANG, G. H. DINGI, T. S. YANG, S. L. JIANG, L. WANG, L. J. XUN, R. M. SONG, Z. S. SONG, B. ZHOU

DOI: 10.4149/neo_2015_076

Association between computed tomography-detected calcification and thyroid carcinoma (641 — 645)

W. LIU, X. DONG, C. ZHU, J. YANG, J. YANG, K. SHAO, L. YUAN, H. CHEN, W. LU, Y. ZHU

DOI: 10.4149/neo_2015_077

FBXO32, a new TGF-β/Smad signaling pathway target gene, is epigenetically inactivated in gastric cardia adenocarcinoma (646 — 657)

W. GUO, M. ZHANG, Y. GUO, S. SHEN, X. GUO, Z. DONG

DOI: 10.4149/neo_2015_078

Impact of the 21-Gene Recurrence Score Assay in adjuvant chemotherapy selection for node-negative, hormone receptor-positive breast cancer in the Chinese population (658 — 665)

Y. N. ZHANG, Y. D. ZHOU, F. MAO, Q. SUN

DOI: 10.4149/neo_2015_079

Expression of IAP family proteins and its clinical importance in breast cancer patients (666 — 673)

P. PLUTA, A. JEZIORSKI, A. PLUTA,B. CEBULA-OBRZUT, A. WIERZBOWSKA, J. PIEKARSKI, P. SMOLEWSKI

DOI: 10.4149/neo_2015_080

Acute toxicity of robotic ultrahypofractionated radiotherapy CyberKnifeTM in prostate cancer patients (674 — 682)

G. GLOWACKI, W. MAJEWSKI, P. WOJCIESZEK, K. GRABINSKA, E. CHAWINSKA, D. BODUSZ, G. WOZNIAK, H. URBANCZYK, A. KALETKA, L. MISZCZYK

DOI: 10.4149/neo_2015_081